Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference

News > Health News

Audio By Carbonatix

7:00 AM on Friday, February 20

The Associated Press

HAYWARD, Calif.--(BUSINESS WIRE)--Feb 20, 2026--

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced plans to present at the upcoming 46 th Annual TD Cowen Healthcare Conference in Boston.

Pulse Biosciences’ Management is scheduled to present on Wednesday, March 4, 2026, at 1:10 pm ET. A live and recorded webcast of the presentation will be available on the “Events Calendar and Presentations” page of the company’s investor website at http://investors.pulsebiosciences.com/.

About Pulse Biosciences®

Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the intention as well as potential to improve the quality of life for patients. The Company’s proprietary nPulse™ technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is actively pursuing the development of its nPulse technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers, such as surgical soft tissue ablation.

Pulse Biosciences, nPulse, Vybrance, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260220245612/en/

CONTACT: Investors:

Pulse Biosciences, Inc.

Jon Skinner, CFO

[email protected]

Gilmartin Group

Philip Trip Taylor

415.937.5406

[email protected]

KEYWORD: CALIFORNIA MASSACHUSETTS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: SURGERY MEDICAL DEVICES HEALTH HEALTH TECHNOLOGY CARDIOLOGY

SOURCE: Pulse Biosciences, Inc.